xo jili casino
With Black Friday sales in full swing, there are still plenty of terrific deals to take advantage of. It’s the perfect time to shop for expensive electronics, including TV’s. Until Cyber Monday, you’ll be able to snag a high-end TV at a nice discount. Several top brands are offering huge deals on their best models. We’re seeing fantastic discounts on Samsung, LG, Sony and Hisense TVs. Whether you want a big-screen TV or something smaller for casual viewing, there are many options to consider getting during this sale event. Last updated on Nov. 30, 2024, at 2 a.m. ET. In this article: Samsung 55-Inch Class QLED 4K The Frame Series Smart TV , LG 77-Inch Class OLED B4 Series Smart TV and Hisense U6 Series 65-Inches ULED 4K Smart TV . Best Black Friday TV deals 2024 Samsung 55-Inch Class QLED 4K The Frame Series Smart TV 40% OFF The cool thing about this smart TV is that it features an Art mode you can enable, which displays modern and classic art pieces whenever you’re not watching. The color volume is fantastic, the matte film reduces light glare and the frame is customizable with multiple color bezel options. Samsung 65-Inch Class Crystal UHD 4K Series Smart TV 14% OFF If you’re looking for an affordable 4K smart TV, this 65-inch LED model won’t disappoint. Motion Xcelerator reduces blur and lag, and object tracking delivers impressive 3D surround sound. It supports HDR and Mega Contrast to minimize the difference between light and dark areas. Roku 55-Inch Select Series 4K HDR Roku TV 29% OFF This Roku TV offers a sharp 4K resolution and supports HDR10+ technology, which enhances color, contrast and brightness. The home screen is customizable with shortcuts to your favorite apps, and the voice remote lets you effortlessly search for paid and free content. Amazon Fire TV 40-Inch 2-Series HD Smart TV 40% OFF Are you looking for a solid TV for casual viewing? This 40-inch Amazon Fire TV has plenty to offer. The Fire TV platform provides quick access to live TV, video games and music, and the remote has a dedicated Alexa button for launching apps, searching for content and controlling smart devices on your network. Samsung 55-Inch Class QLED 4K Q60D Series Quantum HDR Smart TV 38% OFF This TV boasts Quantum Dot technology for reproducing stunning visuals and bright colors. When mounted, its AirSlim design allows it to blend seamlessly with your wall. The advanced processor automatically transforms non-UHD content into 4K and improves sound. LG 77-Inch Class OLED B4 Series Smart TV You’d be hard-pressed to find a better TV for your home entertainment hub than this 77-inch LG smart TV. OLED technology produces accurate colors and deep blacks, and the a8 AI processor automatically fine-tunes the picture quality based on what you’re watching. Plus, it features NVIDIA G-Sync, AMD FreeSync Premium and VRR for improved gaming. Samsung 65-Inch Class OLED 4K S90D Series HDR+ Smart TV 36% OFF This high-end smart TV boasts advanced OLED HDR+ technology, which enhances image brightness and clarity. Dolby Atmos and Object Tracking Sound Lite produce excellent sound quality, and the 144-hertz refresh rate delivers ultrasmooth motion for gaming and live sports. Plus, the smart Tizen OS offers streaming and gaming access. Insignia 42-Inch Class F20 Series Smart Fire TV 33% OFF If you want a cheap smart TV for a smaller room in your home, this 42-inch Insignia Fire TV is the one for you. It’s a full HD TV with a 1080p resolution and a built-in Fire TV interface for streaming content from apps such as Netflix, Prime Video and Disney+. The Alexa voice remote makes it easy to find your favorite movies. Hisense U6 Series 65-Inches ULED 4K Smart TV 29% OFF This Hisense 65-inch TV features advanced Mini-LED technology for reproducing dark blacks and vibrant colors. Dolby Vision delivers superior picture quality, and the dedicated game mode provides a variable refresh rate for smooth gaming. The voice remote is convenient for finding content, and the smart TV interface is intuitive. TCL 98-Inch Q65 QLED 4K UHD Smart TV 47% OFF If you have the space in your home for this massive TV, you’ll love the cinematic experience it offers. QLED technology delivers dazzling visuals and rich colors, and HDR Pro+ boosts contrast, brightness and clarity no matter what you watch. It has an integrated Google TV interface and is compatible with Alexa. More TV deals Amazon Fire TV 43-Inch 4-Series 4K UHD Smart TV 38% OFF Amazon Fire TV 65-Inch Omni QLED Series 4K UHD Smart TV 25% OFF Amazon Fire TV 50-Inch Omni Series 4K UHD Smart TV 31% OFF Sony 75-Inch 4K Ultra HD Google TV Bravia TV 28% OFF Samsung 55-Inch Class QLED 4K Q80D Series Quantum HDR+ Smart TV 33% OFF LG 86-Inch Class UHD Smart TV 23% OFF LG 55-Inch Class QNED85T Series LED Smart TV 13% OFF Prices listed reflect time and date of publication and are subject to change. Check out our Daily Deals for the best products at the best prices and sign up here to receive the BestReviews weekly newsletter full of shopping inspo and sales. BestReviews spends thousands of hours researching, analyzing and testing products to recommend the best picks for most consumers. BestReviews and its newspaper partners may earn a commission if you purchase a product through one of our links.These AI tools offer help to commercial real estate pros
United Internet AG (OTCMKTS:UDIRF) Short Interest Down 83.6% in DecemberNebraska saw a football player announce a transfer for a third straight day Wednesday, this time a rotational member of the defensive line. Kai Wallin will move on after two seasons as a Husker, he announced on social media. He appeared in 11 games this fall with four tackles and recorded half a sack at Purdue. The 6-foot-5, 250-pounder said he “deliberated, consulted and prayed” about his decision. “While I hope to continue to grow and evolve and make an impact on a new field, I will never forget the honor it was to wear a Nebraska jersey,” Wallin wrote in part. Wallin played a year of junior-college ball before arriving at Nebraska in 2023. The Sacramento native redshirted his first season before logging 89 snaps this year including 13 against Wisconsin. He saw single-digit snaps in five games behind a senior-heavy starting line. People are also reading... Blue Springs family to host 2025 Cattleman's Ball At the courthouse, Nov. 30, 2024 Shoplifting investigation leads to arrest for possession of controlled substance They fell in love with Beatrice. So they opened a store in downtown. Nebraska football signing day preview: Potential flips and a 5-star up for grabs Hospice foundation helps with extra support Gage County Sheriff's Office helps catch Fairbury suspect Mother to Mother supporting families 'The Message' religious sect sprouts destructive groups across globe Search warrants lead to arrest of man in narcotics investigation At the courthouse, Nov. 23, 2024 Beatrice company seeks to break China's stranglehold on rare-earth minerals Board of Supervisors denies permit for Filley telecom tower Black Friday starts a busy weekend of serving customers Shatel: Emotions are still simmering, but Nebraska delivered the bottom line for 2024 — a bowl game The defender has two years of eligibility remaining. Wallin is the 10th Husker to announce his intent to enter the transfer portal since Nov. 25. Migration among defenders has been higher as defensive coordinator Tony White and defensive line coach Terrance Knighton both left in recent days for Florida State. NU coach Matt Rhule said earlier Wednesday the roster churn – especially attrition – will continue in earnest as the team continues to trim closer to next season’s mandated limit of 105. “There’s going to be more,” Rhule said. “Everybody’s journey is different.” Get local news delivered to your inbox!
NASHUA, N.H., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Further to a release issued under the same headline on November 26, 2024 13:00 ET by iCAD, Inc., the headline and fourth paragraph have been updated to acknowledge a pending trademark application for the mark "SecondReadAI" by Lunit, Inc. The corrected release follows: iCAD, Inc . ICAD ("iCAD" or the "Company"), a global leader in clinically proven AI-powered cancer detection solutions, will showcase its groundbreaking breast health AI technologies at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago, December 1-5. Key highlights include the recent FDA-cleared ProFound Detection Version 4, clinical research presentations, and a new partnership with Cascaid Health to expand access to AI-driven breast health solutions. iCAD and Cascaid Health Partner to Expand Access to AI-Driven Breast Health In alignment with their vision to enable all women to access to AI-powered breast health services, iCAD and Cascaid Health will unveil their collaboration to integrate the ProFound AI Breast Health Suite into Cascaid's leading edge digital health marketplace and access to care platform. Scheduled for beta launch in Q1 2025, this partnership between iCAD and Cascaid Health will launch ProFound Health, a virtual care model powered by Cascaid. ProFound Health will enable women who have not otherwise received an AI-read on their screening mammogram to access iCAD's advanced breast health technology. The initiative reflects both companies' dedication to democratizing access to life-saving technology and creating a world where cancer can't hide. ProFound Health partnership will offer virtual second reads of mammograms leveraging ProFound AI Breast Health Suite, an AI service providing patients without access to AI an opportunity to receive enhanced breast health insights. The initial service will include a second read detection, breast density assessment, and cancer risk evaluation from a Cascaid-affiliated specialist network of clinical experts in women's health through Cascaid's seamlessly integrated digital platform. By combining AI insights with expert clinical reviews, ProFound Health ensures that patients everywhere, regardless of location, can receive precision screening and personalized care. "ProFound Health empowers patients with access to critical information about their mammograms and overall breast health, allowing them to make informed decisions and take control of their care journey," said Dana Brown, CEO and President of iCAD. "Our collaboration with Cascaid Health's network of clinicians and AI-powered solutions is part of our ongoing commitment to bridging gaps in breast cancer care, ensuring all patients everywhere can access the accuracy and timeliness of AI solutions, and ultimately transforming patient outcomes." "We believe that every woman should have access to the best possible information about her breast health and a high quality, personalized care plan to catch cancer early or prevent it altogether. Through our partnership with iCAD, we're addressing a critical need to improve access to advanced breast health services," said Dr. Candace Westgate, Director of Women's Health for Cascaid Health. "ProFound Health is more than just a technological innovation, it's a lifeline that empowers patients and healthcare providers with actionable insights, bridging care gaps and ensuring equitable access to precision screening and personalized breast cancer care." Advancing Next Generation AI Breast Health Solutions at RSNA 2024 In addition to ProFound Health, iCAD will feature its flagship ProFound Detection Version 4.0, which recently received FDA clearance. This next-generation AI solution enhances breast cancer detection by incorporating prior exams into current analysis, improving the detection of aggressive cancers by 22%, reducing cases with no marks by 18%, and providing clinicians with more reliable insights for better decision-making. "Every two minutes, someone loses their life to breast cancer—a disease affecting over 2.3 million women annually. Early detection is critical, as five-year survival rates exceed 99% for stage 1 disease. Yet traditional mammography misses over 20% of breast cancers, particularly in dense tissue, resulting in potentially avoidable late-stage diagnoses," said Dana Brown, President and CEO of iCAD, Inc. "ProFound Detection Version 4 revolutionizes breast cancer detection by uniquely integrating prior exams into its analysis. This advanced capability enhances sensitivity, sharpens precision, and provides radiologists with a deeper, longitudinal view of a patient's breast health. By enabling earlier and more accurate detection, especially in dense tissue, ProFound Detection Version 4 sets a new standard in breast health AI, empowering providers to improve outcomes and save lives. Together with our strategic partnerships, we are advancing the fight against cancer and making a meaningful difference for patients worldwide." ICAD'S RSNA 2024 Program Highlights AI-Powered Insights: Advancing Cancer Detection Oral Abstract Presentation : "Real World Effect of Artificial Intelligence on Histopathology and Stage in Breast Cancer Screening" Presenter : Kathy Schilling, M.D., Boca Raton Regional Hospital When : Sunday, December 1 | 10:30–11:30 AM Where : S406A: S2-SSBR01-6 Details : Dr. Kathy Schilling discusses the experience with tenured radiologists on how the current use of ProFound AI improves cancer detection, even in women with dense breast tissue, compared to their performance prior to the implementation of AI. In addition, she will describe the decrease in the mean size and stage of cancers after the implementation, along with an increase in the diagnosis of lobular cancers. "The integration of ProFound AI alongside our nine dedicated breast radiologists has demonstrated remarkable improvements in cancer detection and patient outcomes across our imaging network," said Dr. Kathy Schilling, Medical Director of the Christine E. Lynn Women's Health & Wellness Institute at Boca Raton Regional Hospital. "We've seen a 23% overall increase in cancer detection rates, a 4% rise in invasive cancer detection, and doubled rates of lobular cancer detection. ProFound AI also enhanced detection in dense breast tissue by 32%, reduced invasive cancer size by 12%, and lowered histopathologic stage with a 40% reduction in T2 tumors—all without increasing DCIS diagnoses or recall rates. These advancements underscore the transformative potential of AI in improving early breast cancer detection, elevating patient care, and ultimately saving lives." AI Theater Presentation : "The Thin White Line: Which Calcifications Matter? Advances in AI Breast Cancer Detection" Presenter : Chirag R. Parghi, M.D., M.B.A., Solis Mammography When : Tuesday, December 3 | 1:00–1:20 PM Where : AI Showcase Theater (South Hall A), Booth 5536 Details : A look at how ProFound Detection's next-generation capabilities reduce uncertainty in interpreting calcifications on a mammogram by displaying 20% fewer marks related to vascular calcifications and 51% fewer marks related to non-vascular calcifications, leading to enhanced precision and accuracy. Collaborative Panels and Partner Showcases GE HealthCare Expert Corner : Seamless integration of ProFound AI with GE mammography systems to enhance workflow and detection capabilities. Daily at Booth 7330 (North Hall). Densitas Panel : "Elevating Patient Care through Quality Images & Precise Detection." Daily at Booth 4747 (South Hall). CancerIQ : Daily at Booth 4747(South Hall). Blackford Panel : "Enhancing Breast Cancer Care with AI." Tuesday, December 3, 2:30-2:50 PM at Booth 4729 (South Hall). CARPL.ai Breast AI Panel : Wednesday, December 4, 11:00 AM at Booth 5733 (South Hall). Customer Appreciation Event iCAD will be hosting a customer appreciation event, "AI in the Sky: Discover ProFound Insights & Breast Health Innovations," on Sunday, December 1, at 6:00 PM at VU Rooftop in Chicago. Network with industry experts, hear insights from key opinion leaders including iCAD's CEO and Board of Directors, and explore how iCAD's solutions are transforming breast health. Visit the iCAD RSNA 2024 event page for the latest updates, event details, and partnership announcements. About Cascaid Health Cascaid Health Inc. delivers a personalized, expert-driven proactive and preventative approach, supported by an integrated platform designed to promote longevity, detect issues early, reverse risks, and optimize healthspan for all. The company's platform offers a curated marketplace featuring innovative products, services, and access to world-class multidisciplinary experts in women's health, precision health, lifestyle medicine, wellness, and performance. Cascaid Health Inc. is committed to advancing health equity, ensuring that cutting-edge healthcare solutions are accessible to everyone. About iCAD, Inc. iCAD, Inc. ICAD is a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect cancer earlier and improve patient outcomes. Headquartered in Nashua, N.H., iCAD's industry-leading ProFound Breast Health Suite provides AI-powered mammography analysis for breast cancer detection, density assessment and risk evaluation. Used by thousands of providers serving millions of patients, ProFound is available in over 50 countries. In the last five years alone, iCAD estimates reading more than 40 million mammograms worldwide, with nearly 30% being tomosynthesis. For more information, including the latest in regulatory clearances, please visit www.icadmed.com . Forward-Looking Statements Certain statements contained in this News Release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about the expansion of access to the Company's products, improvement of performance, acceleration of adoption, expected benefits of ProFound AI®, the benefits of the Company's products, and future prospects for the Company's technology platforms and products. Such forward-looking statements involve a number of known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of the Company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited, to the Company's ability to achieve business and strategic objectives, the willingness of patients to undergo mammography screening, whether mammography screening will be treated as an essential procedure, whether ProFound AI will improve reading efficiency, improve specificity and sensitivity, reduce false positives and otherwise prove to be more beneficial for patients and clinicians, the impact of supply and manufacturing constraints or difficulties on our ability to fulfill our orders, uncertainty of future sales levels, to defend itself in litigation matters, protection of patents and other proprietary rights, product market acceptance, possible technological obsolescence of products, increased competition, government regulation, changes in Medicare or other reimbursement policies, risks relating to our existing and future debt obligations, competitive factors, the effects of a decline in the economy or markets served by the Company; and other risks detailed in the Company's filings with the Securities and Exchange Commission. The words "believe," "demonstrate," "intend," "expect," "estimate," "will," "continue," "anticipate," "likely," "seek," and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release. For additional disclosure regarding these and other risks faced by iCAD, please see the disclosure contained in our public filings with the Securities and Exchange Commission, available on the Investors section of our website at https://www.icadmed.com and on the SEC's website at http://www.sec.gov . CONTACTS Media Inquiries: pr@icadmed.com Investor Inquiries: John Nesbett/Rosalyn Christian IMS Investor Relations icad@imsinvestorrelations.com © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Shiffrin confirms she'll miss Beaver Creek World Cup racesTrudeau pledged action on border after tariff threat, Trump says